Pattern scan laser photocoagulation: Safety and complications, experience after 1301 consecutive cases

British Journal of Ophthalmology

Volumn 94, Issue 6, 2010, Pages 720-724

  Velez Montoya, Raul ^a   Guerrero Naranjo, José Luis ^a   Gonzalez Mijares, Carmen Cecilia ^a   Fromow Guerra, Jans ^a   Marcellino, George R ^b   Quiroz Mercado, Hugo ^c   Morales Cantón, Virgilio ^a  

^a Asociacion para Evitar la Ceguera en Mexico IAP   (Mexico)

^b OptiMedica Corporation   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; AGED; ARTICLE; BURN; CLINICAL ARTICLE; DRUG SAFETY; FEMALE; HUMAN; LASER COAGULATION; MALE; MEDICAL RECORD REVIEW; OPTICAL INSTRUMENTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA DISEASE; RETINA HEMORRHAGE; RETINA TEAR; RETINA VEIN OCCLUSION; RETINOPEXY; RETROSPECTIVE STUDY; SAFETY;

AGED; DIABETIC RETINOPATHY; FEMALE; HUMANS; LASER COAGULATION; MALE; MIDDLE AGED; RETINAL DETACHMENT; RETINAL HEMORRHAGE; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 77953785459     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.164996     Document Type: Article

References (25)

1. Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976;81:383-96.
2. Diabetic Retinopathy Study Research Group: Photocoagulation treatment of proliferative diabetic retinopathy: clinical applications of diabetic retinopathy study (DRS) findings: DRS report #8. Ophthalmology 1981;88:583-600.
3. Anon. Early treatment diabetic retinopathy study design and base line patient characteristics: ETDRS report number 7. Ophthalmology 1991;98:741-56.
4. Central Vein Occlusion Study Group. Central vein occlusion study of photocoagulation therapy. Baseline findings. Online J Curr Clin Trials 1993;Doc No 95. PMID: 7508322.
5. Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. Ophthalmology 1996;103:352-4.
6. Clark D, Mandal K. Treatment of retinopathy of prematurity. Early Hum Dev 2008;84:95-9.
7. Stefánsson E. Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol 2006;51:364-80. (Pubitemid 43970734)
8. Stefánsson E. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 2001;79:435-40.
9. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Eng J Med 1994;331:1519-20.
10. Wilson CA, Stefánsson E, Klombers L, et al. Optic disk neovascularization and retinal vessel diameter in diabetic retinopathy. Am J Ophthalmol 1988; 106:131-4.
11. Sanghvi C, McLauchlan R, Delgado C, et al. Initial experience with the pascal photocoagulator: a pilot study of 75 procedures. Br J Ophthalmol 2008;92:1061-4.
12. Jain A, Blumenkranz MS, Paulus Y, et al. Effect of pulse duration on size and character of the lesion in retinal photocoagulation. Arch Ophthalmol 2008;126:78-85.
13. Everett AI. Current management of diabetic retinopathy. West J Med 1992;157: 67-70.
14. Blumenkranz MS, Yellachich D, Andersen DA, et al. Semiautomated patterned scanning laser for retinal photocoagulation. Retina 2006;26:370-6. (Pubitemid 44318203)
15. Al-Hussainy S, Dodson PM, Gibson JM. Pain response and follow-up of patients undergoing Panretinal laser photocoagulation with reduced exposure times. Eye 2008;22:96-9.
16. Fong DS, Girach A, Boney A. Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review. Retina 2007;27:816-24. (Pubitemid 47479374)
17. Choi KS, Chung JK, Lim SH. Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular oedema. Korean J Ophthalmol 2007;21:11-17.
18. Nonaka A, Kiryu J, Tsujikawa A, et al. Inflammatory response after scatter laser photocoagulation in nonphotocoagulated retina. Invest Ophthalmol Vis Sci 2002;43:1204-9. (Pubitemid 34258294)
19. Schuele G, Rumohr M, Huettmann G, et al. RPE damage thresholds and mechanisms for laser exposure in the microsecond-to-millisecond time regimen. Invest Ophthalmol Vis Sci 2005;46:714-19. (Pubitemid 40270357)
20. Barrett SF, de Graaf PW, Wright CH. Hybrid tracking system for retinal photocoagulation prototype II. Biomed Sci Instrum 1999;35:259-64.
21. Saxena S, Jalali S, Meredith TA, et al. Management of diabetic retinopathy. Ophthalmol Practice 2000;48:321-30.
22. McAllister IL, Vijayasekaran S, Yu DY, et al. Chorioretinal venous anastomoses: effect of different laser methods and energy in human eyes without vein occlusion. Graefes Arch Clin Exp Ophthalmol 1998;236:174-81. (Pubitemid 28083229)
23. Haupert CL, Grossniklaus HE, Sharara N, et al. Optimal laser power to rupture bruch's membrane and the retinal vein in the pig. Ophthalmic Surg Lasers Imaging 2003;34:122-7. (Pubitemid 36723153)
24. Yuki T, Kimura Y, Nanbus S, et al. Ciliary body and choroidal detachment after laser photocoagulation for diabetic retinopathy. A high-frequency ultrasound study. Ophthalmology 1997;104:1259-64.
25. Doft BH, Blankenship GW. Single versus multiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1982;89:772-9.